文献速递眼底病与葡萄膜炎

羟氯喹视网膜病变患者的荧光寿命特征

Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究对接受羟氯喹筛查的患者进行荧光寿命成像 ophthalmoscope 检查,比较有无视网膜病变患者及健康对照的视网膜平均荧光寿命。结果显示,羟氯喹视网膜病变患者黄斑旁出现环状或椭圆形平均荧光寿命延长区,短光谱通道平均寿命较对照组延长19.4%(P=0.0001);无视网膜病变的用药者与对照组相似。

要点

  • 羟氯喹视网膜病变患者黄斑旁出现环状或椭圆形平均荧光寿命延长区。
  • 病变区短光谱通道平均荧光寿命为374±7 ps,较对照组延长19.4%(P=0.0001)。
  • 无视网膜病变的羟氯喹使用者视网膜荧光寿命与健康对照组相似。

核心结论

  • 羟氯喹视网膜病变表现出特征性的平均荧光寿命改变。

研究设计与样本

  • 研究纳入接受羟氯喹视网膜病变筛查的患者,使用荧光寿命成像 ophthalmoscope 获取短光谱通道(498-560 nm)和长光谱通道(560-720 nm)的视网膜平均荧光寿命(Tm)。
  • 筛查手段包括眼底照相、眼底自发荧光强度图像(FAF)、频域光学相干断层扫描(SD-OCT)、视野和多焦视网膜电图(mfERG)。
  • 共纳入21例羟氯喹治疗患者的42只眼和20名年龄匹配健康对照的40只眼;其中7例羟氯喹视网膜病变患者(平均年龄66.1岁,SD 7.7)的14只眼,以及14例无视网膜病变的羟氯喹治疗患者(平均年龄46.1岁,SD 7.9)的28只眼。

主要发现

  • 羟氯喹视网膜病变患者显示黄斑旁环状或椭圆形平均荧光寿命延长区。
  • 病变区域短光谱通道平均(±SEM)荧光寿命为374±7 ps,较对照组平均延长19.4%(P=0.0001)。
  • 无视网膜病变的羟氯喹治疗患者视网膜荧光寿命与对照组相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate fundus autofluorescence lifetime features in patients with hydroxychloroquine (HCQ) retinopathy, and to identify early markers of retinal alterations in patients due to HCQ. METHODS: Patients attending screening for HCQ retinopathy were imaged with a fluorescence lifetime imaging ophthalmoscope. Mean retinal fluorescence lifetimes (Tm) were obtained in a short spectral channel (SSC, 498-560 nm) and a long spectral channel (LSC, 560-720 nm). Screening modalities included fundus images, fundus autofluorescence intensity images (FAF), spectral-domain optical coherence tomography (SD-OCT), visual fields, and multifocal electroretinogram (mfERG). RESULTS: Forty-two eyes of 21 patients on HCQ therapy and 40 eyes of 20 healthy age-matched controls were included. Fourteen eyes of 7 patients with HCQ retinopathy (mean age, 66.1 [SD, 7.7] years) and 28 eyes of 14 patients (mean age, 46.1 [SD, 7.9] years) receiving HCQ without retinopathy were identified. Patients with HCQ retinopathy showed a parafoveal ring-shaped or oval area of prolonged mean fluorescence lifetimes. In these areas, mean (±SEM) lifetimes were 374 ± 7 ps in the SSC, and on average 19.4% longer compared to the control group (P = 0.0001). Patients on HCQ without retinopathy had retinal fluorescence lifetimes that were similar to the control group. CONCLUSIONS: This study shows that HCQ retinopathy displays characteristic mean fluorescence lifetimes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Solberg Y, Dysli C, Möller B, et al. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy. Invest Ophthalmol Vis Sci. 2019. PMID: 31108547. doi:10.1167/iovs.18-26079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。